Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis

doi:10.5847/wjem.j.1920-8642.2024.016

Abstract

Abstract:

BACKGROUND: Xuebijing (XBJ) can alleviate the inflammatory response, improve organ function, and shorten the intensive care unit (ICU) stay in patients with pyogenic liver abscess (PLA) complicated with sepsis, but the molecular mechanisms have not been elucidated. This study aimed to explore the molecular mechanism of XBJ in treating PLA complicated with sepsis using a network pharmacology approach.
METHODS: The active ingredients and targets of XBJ were retrieved from the ETCM database. Potential targets related to PLA and sepsis were retrieved from the GeneCards, PharmGKB, DisGeNet, Online Mendelian Inheritance in Man (OMIM), Therapeutic Targets Database (TTD), and DrugBank databases. The targets of PLA complicated with sepsis were mapped to the targets of XBJ to identify potential treatment targets. Protein-protein interaction networks were analyzed using the STRING database. Potential treatment targets were imported into the Metascape platform for Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Molecular docking was performed to validate the interactions between active ingredients and core targets.
RESULTS: XBJ was found to have 54 potential treatment targets for PLA complicated with sepsis. Interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF) were identified as core targets. KEGG enrichment analysis revealed important pathways, including the interleukin-17 (IL-17) signaling pathway, the TNF signaling pathway, the nuclear factor-kappa B (NF-κB) signaling pathway, and the Toll-like receptor (TLR) signaling pathway. Molecular docking experiments indicated stable binding between XBJ active ingredients and core targets.
CONCLUSION: XBJ may exert therapeutic effects on PLA complicated with sepsis by modulating signaling pathways, such as the IL-17, TNF, NF-κB, and TLR pathways, and targeting IL-1β, IL-6, and TNF.

Key words: Xuebijing injection, Pyogenic liver abscess, Sepsis

Wei Zhou, Maiying Fan, Xiang Li, Fang Yu, En Zhou, Xiaotong Han. Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis[J]. World Journal of Emergency Medicine, 2024, 15(1): 35-40.

Figures/Tables 4

Figure 1.

Figure 2.

Table 1.

Figure 3.

References 25

1	Li WF, Chen HJ, Wu S, Peng J. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol. 2018; 18(1):144. doi: 10.1186/s12876-018-0875-y pmid: 30285638
2	Qi WQ, Huang CM, Bian F, Ge Q. Risk factors and early diagnosis of sepsis caused by liver abscess. Chin J Emerg Med. 2019; 28:1383-9.
3	Wei JX, Jiang HL, Chen XH. Endothelial cell metabolism in sepsis. World J Emerg Med. 2023; 14(1):10-6. doi: 10.5847/wjem.j.1920-8642.2023.019
4	Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, et al. Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med. 2023; 183(7):647-55. doi: 10.1001/jamainternmed.2023.0780 pmid: 37126332
5	Meng X, Yang S, Cao Y, Zhao M. The clinical effect of Xuebijing on the patients with bacterial liver abscess and sepsis. Chin J Critical Care Med. 2019, 39(11):1050-2.
6	Li X, Wei SZ, Niu SQ, Ma X, Li HT, Jing MY, et al. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput Biol Med. 2022; 144: 105389. doi: 10.1016/j.compbiomed.2022.105389
7	Liu JQ, Liu J, Tong XL, Peng WJ, Wei SS, Sun TL, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Dev Ther. 2021; 15: 3255-76. doi: 10.2147/DDDT.S319786 pmid: 34349502
8	Zhou YY, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. doi: 10.1038/s41467-019-09234-6 pmid: 30944313
9	Zhou W, Fan M, Tang Y, Guo H, Tan Z, Han X, et al. Effect of Xuebijing on inflammatory response and clinical efficacy in patients with sepsis. Int J Urol Nephrol. 2023; 43(1):97-100.
10	Zhao L, Chen F, Zhang YL, Yue L, Guo HR, Ye G, et al. Involvement of P450s and nuclear receptors in the hepatoprotective effect of quercetin on liver injury by bacterial lipopolysaccharide. Immunopharmacol Immunotoxicol. 2020; 42(3):211-20. doi: 10.1080/08923973.2020.1742154
11	Tang J, Diao P, Shu XH, Li L, Xiong LD. Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264.7 cells: in vitro assessment and a theoretical model. Biomed Res Int. 2019; 2019:7039802.
12	Karimi A, Naeini F, Asghari Azar V, Hasanzadeh M, Ostadrahimi A, Niazkar HR, et al. A comprehensive systematic review of the therapeutic effects and mechanisms of action of quercetin in sepsis. Phytomedicine. 2021; 86:153567. doi: 10.1016/j.phymed.2021.153567
13	Zhang ZH, Yang HX, Jin Q, Wu YL, Cui ZY, Shang Y, et al.Luteolin attenuates hepatic injury in septic mice by regulating P2X7R-based HMGB1 release. Food Funct. 2021; 12(21): 10714-27. doi: 10.1039/D1FO01746B
14	Vajdi M, Karimi A, Karimi M, Abbasalizad Farhangi M, Askari G. Effects of luteolin on sepsis: a comprehensive systematic review. Phytomedicine. 2023; 113:154734. doi: 10.1016/j.phymed.2023.154734
15	Gao J, Yin J, Shen WJ, Shen W, Wang SY, Yao P. The effect of kaempferol on liver function injury in septic rats and its relationship with HIF-1α/HK2 signaling pathway. Chin J Crit Care Med. 2023; 43(4):279-84.
16	Zhu X, Wang XL, Ying TH, Li XL, Tang YD, Wang YF, et al. Kaempferol alleviates the inflammatory response and stabilizes the pulmonary vascular endothelial barrier in LPS-induced sepsis through regulating the SphK1/S1P signaling pathway. Chem Biol Interact. 2022; 368:110221. doi: 10.1016/j.cbi.2022.110221
17	Guo HL, Shi FD, Zhou Q, Liu QY, Wang YX, Song Y, et al. Interleukin-1β protection against experimental sepsis in mice. Inflammation. 2021; 44(1):358-70. doi: 10.1007/s10753-020-01341-7
18	Xiong SQ, Hong ZG, Huang LS, Tsukasaki Y, Nepal S, Di AK, et al. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest. 2020; 130(7):3684-98. doi: 10.1172/JCI136908 pmid: 32298238
19	Cao J, Liu WG, Li Y, Chen B, Yu TF, He ZB, et al. Value of IL-1β and IL-23 in predicting 28-day mortality due to sepsis: a retrospective study. Med Sci Monit. 2023; 29:e940163.
20	Roderburg C, Benz F, Schüller F, Pombeiro I, Hippe HJ, Frey N, et al. Serum levels of TNF receptor ligands are dysregulated in sepsis and predict mortality in critically ill patients. PLoS One. 2016; 11(4):e0153765. doi: 10.1371/journal.pone.0153765
21	Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022; 44(4):445-59. doi: 10.1007/s00281-022-00910-2 pmid: 35122118
22	Guo Y, Chen L, Zheng Q, Chen J, Cai J, Cao H, et al. Effects of inhibition of IL-6/STAT3 signaling pathway on liver injury in septic rats. Chin J Trauma. 2011; 27(11):1049-52.
23	Hu P, Chen Y, Pang J, Chen X. Association between IL-6 polymorphisms and sepsis. Innate Immun. 2019; 25(8):465-72. doi: 10.1177/1753425919872818
24	Kumar V.Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020; 89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087
25	Yan BL, Chen F, Xu LJ, Xing JH, Wang XF. HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice. Sci Rep. 2017; 7:597. doi: 10.1038/s41598-017-00721-8 pmid: 28377603

[1]	Hui Chen, Yuanhua Lu, Songjie Bai, Yang Li, Tao Wang, Long Cai, Xinyi Yang, Yang Fang, Jianguo Wan, Yaqun Tang, Wenqiang Tao, Meiling Huang, Wei Zhong, Fen Liu, Kejian Qian. Stress-hyperglycemia ratio and glycemic variability predict severity and mortality in sepsis-associated acute respiratory distress syndrome [J]. World Journal of Emergency Medicine, 2026, 17(3): 250-257.
[2]	Yi Yao, Wenjin Li, Dejiang Hong, Ze Chen, Kai Peng, Guangju Zhao. Prediction model for quality of life in sepsis survivors one year after discharge [J]. World Journal of Emergency Medicine, 2026, 17(2): 105-112.
[3]	Zengzheng Ge, Xin Lu, Shiyuan Yu, Mubing Qin, Chao Gong, Qun Xu, Yanxia Gao, Joseph Harold Walline, Huadong Zhu, Yi Li. Diagnostic value of mismatch-negativity and P3a event-related potentials for sepsis-associated encephalopathy in non-sedated patients: a pilot study [J]. World Journal of Emergency Medicine, 2026, 17(2): 172-178.
[4]	Jinlan Ma, Li Peng, Hongming Yu, Jianfeng Xie, Ying Tang, Shenglin Su, Libing Ma, Xiaojun Yang. Single-cell transcriptomics reveals pathogen-specific monocyte heterogeneity and potential biomarkers in gram-positive versus gram-negative bloodstream infections [J]. World Journal of Emergency Medicine, 2026, 17(2): 162-171.
[5]	Xin Lu, Mubing Qin, Zengrui Song, Ying Chen, Huadong Zhu, Yanxia Gao, Yi Li. Normal initial lactate level in sepsis patients: is lactate still useful for prognosis prediction? [J]. World Journal of Emergency Medicine, 2026, 17(1): 57-64.
[6]	Yuhui Pan, Yanyan Ma, Ke Wan, Yizhou Xu, Guoxing Wang, Miaorong Xie. Endothelial cell injury: a crucial link in microcirculatory dysfunction associated with sepsis [J]. World Journal of Emergency Medicine, 2026, 17(1): 28-35.
[7]	Wei Gu, Jie Zhong, Chuanzhu Lyu, Guoqiang Zhang, Miaorong Xie, Yuefeng Ma, Wei Guo. An approach for the emergency diagnosis and treatment of sepsis-associated encephalopathy in elderly individuals: a literature review [J]. World Journal of Emergency Medicine, 2025, 16(5): 415-422.
[8]	Zesheng Wu, Fanghui Chen, Chen Xiao, Xue Zhao, Yuansheng Xu, Jinyan Fang, Yinyan Shao. Long-term cardiovascular outcomes and risk factors in adult sepsis survivors: a systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2025, 16(5): 423-430.
[9]	Qiaosheng Wang, Qiong Luo, Zhiwei Su, Yan Xu, Liangshan Peng, Yin Wen, Hongke Zeng, Hongguang Ding. Activation of the α7 nicotinic acetylcholine receptor mitigates cognitive deficits in mice with sepsis-associated encephalopathy by inhibiting microglial pyroptosis [J]. World Journal of Emergency Medicine, 2025, 16(5): 438-446.
[10]	Sen Jiang, Xiandong Liu, Tong Liu, Yi Gu, Bo An, Chunxue Wang, Dongyang Zhao, Haitao Zhang, Lunxian Tang. Performance of a novel medical artificial intelligence large language model on supporting decision-making for emergency patients with suspected sepsis [J]. World Journal of Emergency Medicine, 2025, 16(5): 447-455.
[11]	Quan Li, Yun Qu, Jinfang Xue, Hai Kang, Chuanzhu Lyu. Exploring lipid-modifying therapies for sepsis through the modulation of circulating inflammatory cytokines: a Mendelian randomization study [J]. World Journal of Emergency Medicine, 2025, 16(3): 256-261.
[12]	Peili Chen, Yan Ge, Huiqiu Sheng, Wenwu Sun, Jiahui Wang, Li Ma, Enqiang Mao. The role of early changes in routine coagulation tests in predicting the occurrence and prognosis of sepsis [J]. World Journal of Emergency Medicine, 2025, 16(2): 136-143.
[13]	Chunxue Wang, Dianyin Yang, Yuxin Zhu, Qian Yang, Tong Liu, Xiandong Liu, Dongyang Zhao, Xiaowei Bao, Tiancao Dong, Li Shao, Lunxian Tang. Circulating circular RNAs act as potential novel biomarkers for sepsis secondary to pneumonia: a prospective cohort study [J]. World Journal of Emergency Medicine, 2025, 16(2): 144-152.
[14]	Azzah S Alharbi, Raghad Hassan Sanyi, Esam I Azhar. Bacteria and host: what does this mean for sepsis bottleneck? [J]. World Journal of Emergency Medicine, 2025, 16(1): 10-17.
[15]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.